Carol A. Nacy

Sequella (United States) — United States

Medicine · Health Sciences

46h-index8.1kcitations153works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Research on Leishmaniasis Studies(52), Tuberculosis Research and Epidemiology(30), Mycobacterium research and diagnosis(18), Parasites and Host Interactions(15), Trypanosoma species research and implications(15)

Publications153 total

panTB-HM: a clinical trial of a pan-TB regimen targeting both host and microbe
2025Open Access
Broad-Spectrum Activity and Mechanisms of Action of SQ109 on a Variety of Fungi
ACS Infectious Diseases·2025· 3 cited
Broad-Spectrum Activity and Mechanisms of Action of SQ109 on a Variety of Fungi
2025Open Access
Structure, <i>In Vivo</i> Detection, and Antibacterial Activity of Metabolites of SQ109, an Anti-Infective Drug Candidate
ACS Infectious Diseases·2021· 16 citedOpen Access
Pharmacokinetics and Target Attainment of SQ109 in Plasma and Human-Like Tuberculosis Lesions in Rabbits
Antimicrobial Agents and Chemotherapy·2021· 23 citedOpen Access
Structure, in Vivo Detection and Anti-Bacterial Activity of Metabolites of SQ109, an Anti-Infective Drug Candidate
2021· 2 citedOpen Access
Structure, in Vivo Detection and Anti-Bacterial Activity of Metabolites of SQ109, an Anti-Infective Drug Candidate
2021· 1 citedOpen Access
Leishmania
2021
<i>N</i> -Acetylglucosamine-1-Phosphate Transferase, WecA, as a Validated Drug Target in Mycobacterium tuberculosis
Antimicrobial Agents and Chemotherapy·2017· 27 citedOpen Access
Tuberculosis — drugs in the 2016 development pipeline
Nature Reviews Disease Primers·2017· 17 citedOpen Access
Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients
Journal of Antimicrobial Chemotherapy·2015· 91 citedOpen Access
Optimization of a Nucleic Acid-Based Reporter System To Detect Mycobacterium tuberculosis Antibiotic Sensitivity
Antimicrobial Agents and Chemotherapy·2014· 8 citedOpen Access
Succumbing to the Mysteries of Microbiology and Immunology
ASM Press eBooks·2014
Atención a la innovación: Existen obstáculos en el desarrollo de medicamentos para luchar contra nuevas enfermedades
Finanzas y desarrollo: publicación trimestral del Fondo Monetario Internacional y del Banco Mundial·2014
Therapeutic Efficacy of SQ641-NE against Mycobacterium tuberculosis
Antimicrobial Agents and Chemotherapy·2013· 45 citedOpen Access
Safety, tolerability and 14-day antimycobacterial activity of the novel antituberculosis compound SQ109
UCL Discovery (University College London)·2013
Early bactericidal activity of new drug regimens for tuberculosis
The Lancet·2013· 8 cited
Discovery and Development of SQ109: A New Antitubercular Drug with a Novel Mechanism of Action
Future Microbiology·2012· 272 citedOpen Access
Generation of a Novel Nucleic Acid-Based Reporter System To Detect Phenotypic Susceptibility to Antibiotics in Mycobacterium tuberculosis
mBio·2012· 13 citedOpen Access
SQ109 and PNU-100480 interact to kill Mycobacterium tuberculosis in vitro
Journal of Antimicrobial Chemotherapy·2012· 44 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Monte S. Meltzer(16), A H Fortier(12), Leo Einck(11), Shawn J. Green(10), Marina Protopopova(8), B. V. Nikonenko(8), Elena Bogatcheva(6), R. M. M. Crawford(5), Venkata M. Reddy(5), Rowena Samala(4), Miodrag Belosevic(4), Colleen F. Hanrahan(3), D S Finbloom(3), M V Slayter(3), R.B. Narayanan(3), Robert D. Schreiber(3), Beverly A. Mock(3), David L. Hoover(3), Koen Andries(2), Barbara J. Nelson(2)